Cerebral venous thrombosis in a child with inflammatory bowel disease: case report
Iranian Journal of Child Neurology,
Vol. 15 No. 3 (2021),
19 June 2021
inflammatory bowel disease (IBD) has both intestinal and extra intestinal manifestations. Inflammatory bowel disease (IBD) is a known risk factor for cerebral venous thrombosis (CVT) event in adult and children. The precise mechanism of thrombotic event is not known in patient with IBD. We report a case of ulcerative colitis with CVT during admission for acute relapse. 12 years old boy known case of ulcerative colitis since 12 months ago admitted in children hospital because of bloody diarrhea, recurrent colicky abdominal pain. At the third day of admission patient had severe headache. Level of consciousness has decreased gradually during 12 hours. Child has been aphasic later. One episode of tonic clonic seizure has happened 18 hours after the onset of headache. Neurologic examination showed right hemiparesis. Physical examinations including blood pressure and fundoscopy were unremarkable in last admission. Brain CT shows intraparanchymal hemorrhage in left temporal lobe with asymmetric increased density in left lateral sinus. The results of MRI has shown abnormal hyperintense signal in left lateral sinus in T1WI and T2WI that is compatible with thrombosis (loss of signal) in MRV. LMW heparin was administered according to consultation with hematologist and continued post discharge. Child condition has improved slowly and neurologic evaluation was normal after 3months. Cerebrovascular events, such as cerebral venous thrombosis (CVT) or cerebral arterial infarction (CAI), are rare extraintestinal manifestations of PIBD but probably the most common forms of thromboembolism in children. Probably, treatment of CVT with anticoagulants is the best way of management. A comprehensive study is essential to understand the choice, efficacy, duration, and primary and secondary prophylaxis protocol with anticoagulants.
- Children; Inflammatory bowel disease; Cerebral venous thrombosis; ‘’Case report”
How to Cite
Katsanos A.H, Katsanos K.H, Kosmidou M, et al. Cerebral sinus venous thrombosis in inflammatory
bowel diseases. Q J Med 2013; 106:401–413
Zois CD, Katsanos KH, Kosmidou M, et al. Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis 2010; 4:115–24.
Benavente L, Moris G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol 2011; 18:138–43.
Scheid R, Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 2007; 14:483–93.
Richard S, Fairise A, Lacour JC, et al. Cerebral venous thrombosis in inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16:366–7.
Standridge S, de los Reyes E. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature. J Child Neurol 2008; 23:59–66.
Nylund CM, Goudie A, Garza JM, et al. Venous thrombotic events in hospitalized children and
adolescents with inflammatory bowel disease. JPGN 2013; 56: 485–491
Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011; 60:937–43.
Lazzerini M, Bramuzzo M, Maschio M, Martelossi S, Ventura A. Thromboembolism in pediatric inflammatory bowel disease: systematic review. Inflammatory bowel diseases. 2011 Oct 1;17(10):2174-83.
Umit H, Asil T, Celik Y, Tezel A, Dokmeci G, Tuncbilek N, et al. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World Journal of gastroenterology. 2005;11(34):5404.
Korzenik JR. IBD: a vascular disorder? The case for heparin therapy. Inflammatory bowel diseases. 1997;3(2):87-94.
Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993;34:247–51.
Chamouard P, Grunebaum L, Wiesel ML, et al. Prothrombin fragment 12 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995;7:1183–8.
Talbot RW, Heppell J, Dozois R, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140–5.
Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis 1978;23:897– 902.
Mahmood A, Needham J, Prosser J, et al. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol
Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40:1883–9.
Jorens PG, Hermans CR, Haber I, et al. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut 1990;61:307–10.
Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb 2002;32:92–6.
Koutroubakis IE, Sfiridaki A, Mouzas IA, et al. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:190–4.
Saibeni S, Vecchi M, Valsecchi C, et al. Reduced free protein S levels in patients with inflammatory bowel disease: prevalence, clinical relevance, and role of anti-protein S antibodies. Dig Dis Sci 2001;46:637– 43.
. Faioni EM, Ferrero S, Fontana G, et al. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 2004;32:S266–70.
Bjerregaard LT, Nederby NJ, Fredholm L, et al. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol
Nakano E, Taylor CJ, Chada L, et al. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003; 37:586–90.
Oldenburg B, Van Tuyl BA, van der Griend R, et al. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci 2005;50:235–40.
Petitpain N, Gambier N, Wahl D, et al. Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000–2006. Biomed Mater Eng. 2009;19:
Zitomersky NL, Verhave M, Trenor CC 3rd. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention.
Jibaly R, Kaddourah A. Venous sinus thrombosis in a child with ulcerative colitis: P‐0010. Inflammatory Bowel Diseases. 2009;15:S7.
Keene DL, Matzinger MA, Jacob PJ, Humphreys P. Cerebral vascular events associated with ulcerative colitis in children. Pediatric neurology. 2001;24(3):238-43.
MiehslerW, ReinischW, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542–8.
Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004;99:97–101.
Angelberger S, Miehsler W, Novacek G. Colonic involvement does not predispose to thrombosis in IBD. Inflamm Bowel Dis 2009;15:316–7.
Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology. 1978;28(6):571
- Abstract Viewed: 431 times
- pdf Downloaded: 0 times